URSO

This brand name is authorized in Canada, Japan, United States

Active ingredients

The drug URSO contains one active pharmaceutical ingredient (API):

1 Ursodeoxycholic acid UNII 724L30Y2QR - URSODIOL

The ursodeoxycholic acid converts lithogenic bile in non-lithogenic bile and gradually dissolves the cholesterol gallstones. Read about Ursodeoxycholic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
URSO 250 / FORTE Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A05AA02	Ursodeoxycholic acid	A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AA Bile acid preparations
Discover more medicines within A05AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02238984, 02245894
Country: JP	医薬品医療機器総合機構	Identifier(s): 2362001F1088, 2362001F2149
Country: US	FDA, National Drug Code	Identifier(s): 58914-785, 58914-790